Literature DB >> 4400958

Preclinical evaluation of the interrelationships between cancer chemotherapy and immunity.

E Mihich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4400958

Source DB:  PubMed          Journal:  Natl Cancer Inst Monogr        ISSN： 0083-1921


× No keyword cloud information.
  5 in total

Review 1.  Adapting conventional cancer treatment for immunotherapy.

Authors:  Jian Qiao; Zhida Liu; Yang-Xin Fu
Journal:  J Mol Med (Berl)       Date:  2016-02-24       Impact factor: 4.599

2.  Complete remission of liver metastases from colorectal cancer by treatment with a hepatic artery infusion (HAI) of interleukin-2-based immunochemotherapy: reports of three cases.

Authors:  K Okuno; H Ohnishi; I Nakajima; Y Akabane; K Kurooka; K Koh; K Shindo; M Yasutomi
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

3.  Systemic activation of macrophages by liposome-entrapped muramyl tripeptide in mice pretreated with the chemotherapeutic agent adriamycin.

Authors:  G Hisano; I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

Review 4.  Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer.

Authors:  Tianqian Zhang; Dorothee Herlyn
Journal:  Cancer Immunol Immunother       Date:  2008-10-17       Impact factor: 6.968

5.  Protective specific immunity induced by cyclophosphamide plus tumor necrosis factor alpha combination treatment of EL4-lymphoma-bearing C57BL/6 mice.

Authors:  C M Krawczyk; S Verstovsek; P Ujházy; D Maccubbin; M J Ehrke
Journal:  Cancer Immunol Immunother       Date:  1995-06       Impact factor: 6.968
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.